The Coalition for Epidemic Preparedness Innovations (CEPI) issued a new call for proposals inviting organisations around the world to apply for funding to speed up development, scale-up manufacturing, and expand the geographical footprint of production of COVID-19 vaccine candidates. The call will be open until at least 30 June 2020 with applications reviewed on a rolling basis every two weeks. Applicants must be developing vaccines that can be approved in 12-18 months or less, and be in a position to increase the availability of vaccines for wide-spread global deployment. Since January CEPI has established a COVID-19 vaccine development portfolio comprising nine candidates, three of which in clinical testing. Following the World Health Organisation’s launch last month of the Access to COVID-19 tools accelerator, CEPI is now seeking to expand and diversify its portfolio.